Anchor Capital Advisors LLC Abbott Laboratories Transaction History

Anchor Capital Advisors LLC

$3.51 Billion
Q3 2024

A detailed history of Anchor Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 142,912 shares of ABT stock, worth $16.9 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

142,912

Previous 144,513 1.11%

Holding current value

$16.9 Million

Previous $15 Million 8.5%

% of portfolio

0.46%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$100.07 - $118.13 $160,212 - $189,126	-1,601 Reduced 1.11%	142,912 $16.3 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $2.37 Million - $2.64 Million	23,482 Added 19.4%	144,513 $15 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $1.46 Million - $1.61 Million	-13,319 Reduced 9.91%	121,031 $13.8 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $111,204 - $136,123	-1,233 Reduced 0.91%	134,350 $14.8 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $346,391 - $415,612	-3,626 Reduced 2.6%	135,583 $13.1 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $352,125 - $392,341	-3,494 Reduced 2.45%	139,209 $15.2 Million
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $39,422 - $46,402	-407 Reduced 0.28%	142,703 $14.5 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $596,311 - $699,564	-6,273 Reduced 4.2%	143,110 $15.7 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $694,736 - $804,375	-7,180 Reduced 4.59%	149,383 $14.5 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $978,443 - $1.18 Million	-9,586 Reduced 5.77%	156,563 $17 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $72,630 - $88,568	-637 Reduced 0.38%	166,149 $19.7 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $383,097 - $469,081	-3,316 Reduced 1.95%	166,786 $23.5 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $141,975 - $157,066	1,217 Added 0.72%	170,102 $20.1 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $177,727 - $209,210	1,680 Added 1.0%	168,885 $19.6 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $1.03 Million - $1.22 Million	9,502 Added 6.03%	167,205 $20 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $415,590 - $452,874	3,958 Added 2.57%	157,703 $17.3 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $143,508 - $174,280	1,566 Added 1.03%	153,745 $16.7 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $5.15 Million - $6.59 Million	-67,272 Reduced 30.65%	152,179 $13.9 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $443,069 - $647,888	-7,053 Reduced 3.11%	219,451 $17.3 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $1.92 Million - $2.14 Million	24,449 Added 12.1%	226,504 $19.7 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $630,249 - $683,386	-7,701 Reduced 3.67%	202,055 $16.9 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $482,174 - $562,360	-6,616 Reduced 3.06%	209,756 $17.6 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $11.2 Million - $13.5 Million	-168,591 Reduced 43.79%	216,372 $17.3 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $350,155 - $396,676	-5,341 Reduced 1.37%	384,963 $27.8 Million
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $1.05 Million - $1.27 Million	-17,271 Reduced 4.24%	390,304 $28.6 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $2.33 Million - $2.57 Million	-40,405 Reduced 9.02%	407,575 $24.9 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $4.6 Million - $5.21 Million	-81,816 Reduced 15.44%	447,980 $26.8 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $1.14 Million - $1.22 Million	-21,297 Reduced 3.86%	529,796 $30.2 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $26.5 Million - $29.6 Million	551,093	551,093 $29.4 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Capital Advisors LLC with notifications on news.

Account

Anchor Capital Advisors LLC Abbott Laboratories Transaction History